Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 21 June, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Krebs Biochemicals & Industries Ltd

About the Company - Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Ltd. is a Public Limited Listed company incorporated on 02/12/1991 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110AP1991PLC103912 and registration number is 103912. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 59.70 Cr. and Equity Capital is Rs. 21.56 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsKothapalli Village, Anakapalli Dist. Andhra Pradesh 531031investors@krebsbiochem.com
http://www.krebsbiochem.com
Management
NamePosition Held
Dr. R T RaviChairman & Non-Exe.Director
Mr. Jitendra ShahManaging Director & CEO
Mr. Pabitrakumar Kalipada BhattacharyyaNon Executive Director
Mr. Avinash RaviNon Executive Director
Mr. G V L PrasadIndependent Director
Mr. Raj Kamal Prasad VermaIndependent Director
Dr. Tangirala MalatiIndependent Director
Mr. Satish KhivsaraIndependent Director

Basic Stock Data of Krebs Biochemicals & Industries Ltd

Last Updated: June 17, 2024, 8:27 pm

Market Cap 157 Cr.
Current Price 72.8
High / Low94.0/60.0
Stock P/E
Book Value 55.3
Dividend Yield0.00 %
ROCE10.4 %
ROE%
Face Value 10.0
PEG Ratio0.00

Competitors of Krebs Biochemicals & Industries Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Colinz Laboratories Ltd 19.5 Cr. 42.750.0/33.439.9 19.60.00 %7.70 %5.73 % 10.0
Suven Pharmaceuticals Ltd 17,004 Cr. 668768/42756.6 80.60.15 %21.1 %15.9 % 1.00
Procter & Gamble Health Ltd 8,275 Cr. 4,9855,643/4,63738.6 4851.87 %45.5 %33.5 % 10.0
Brawn Biotech Ltd 8.04 Cr. 26.827.5/14.4 16.90.00 %27.1 %27.1 % 10.0
Themis Medicare Ltd 2,031 Cr. 221266/13146.7 41.00.23 %13.9 %12.1 % 1.00
Industry Average15,470.18 Cr1,225.2138.83197.710.35%17.41%16.91%6.46

Krebs Biochemicals & Industries Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales9.5815.866.7611.9821.8119.1610.6420.949.0911.4610.5814.8912.98
Expenses15.2320.3813.2919.7631.7128.9416.9122.8412.0716.0813.2015.7915.07
Operating Profit-5.65-4.52-6.53-7.78-9.90-9.78-6.27-1.90-2.98-4.62-2.62-0.90-2.09
OPM %-58.98%-28.50%-96.60%-64.94%-45.39%-51.04%-58.93%-9.07%-32.78%-40.31%-24.76%-6.04%-16.10%
Other Income0.060.440.030.130.200.790.130.270.020.190.040.170.03
Interest1.431.491.511.781.820.280.300.740.901.031.101.131.19
Depreciation1.241.411.421.421.422.051.691.691.691.481.651.711.73
Profit before tax-8.26-6.98-9.43-10.85-12.94-11.32-8.13-4.06-5.55-6.94-5.33-3.57-4.98
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit-8.26-6.99-9.42-10.85-12.94-11.31-8.14-4.06-5.55-6.94-5.33-3.57-4.98
EPS in Rs-4.21-3.56-4.37-5.03-6.00-5.25-3.78-1.88-2.57-3.22-2.47-1.66-2.31

Last Updated: June 6, 2024, 6:23 am

Krebs Biochemicals & Industries Ltd Quarterly Chart

Krebs Biochemicals & Industries Ltd Profit & Loss

MonthMar 2012Jun 2013Sep 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales6911001334483354605250
Expenses732445141141585271946860
Operating Profit-4-13-4-5-12-8-8-10-19-18-34-16-10
OPM %-5%-117%-1,088%-248%-22%-20%-56%-33%-57%-30%-20%
Other Income36031-0-1001110
Interest9104135666534
Depreciation10802444455677
Profit before tax-19-16-4-8-16-16-18-20-29-28-45-25-21
Tax %10%5%-10%0%0%0%0%0%0%0%0%0%
Net Profit-17-15-4-8-16-16-18-20-29-28-45-25-21
EPS in Rs-15.17-13.22-3.78-6.82-10.33-9.67-10.73-12.03-16.04-14.45-20.65-11.45-9.66
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%0%

Krebs Biochemicals & Industries Ltd Profit & Loss Yearly Chart

Krebs Biochemicals & Industries Ltd Growth

Compounded Sales Growth
10 Years:16%
5 Years:1%
3 Years:-2%
TTM:-3%
Compounded Profit Growth
10 Years:-3%
5 Years:0%
3 Years:9%
TTM:20%
Stock Price CAGR
10 Years:15%
5 Years:-2%
3 Years:-15%
1 Year:-2%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:%

Last Updated: June 17, 2024, 2:57 pm

Krebs Biochemicals & Industries Ltd Balance Sheet

MonthMar 2012Jun 2013Sep 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital10101010131414171820222222
Reserves14-2-65-4-12-32-31-43-67-97-121-130
Preference Capital000000003030130130
Borrowings869393613148565336811353188
Other Liabilities3937413377738710312312525222199
Total Liabilities149138138108116122126142134159190175178
Fixed Assets6551585893102101101105118139147154
CWIP070011443412840
Investments0000000000000
Other Assets83808050131621382429432424
Total Assets149138138108116122126142134159190175178

Krebs Biochemicals & Industries Ltd Reserves and Borrowings Chart

Krebs Biochemicals & Industries Ltd Cash Flow

MonthMar 2012Jun 2013Sep 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 7-249-45-15-11-64-36-15-17-25
Cash from Investing Activity -160-3-4-5-3-4-10-23-23-13
Cash from Financing Activity -6-4-4954131691729384037
Net Cash Flow0-006-6-0017-171-1-0

Krebs Biochemicals & Industries Ltd Financial Efficiency Indicators

MonthMar 2012Jun 2013Sep 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days4130101803222254
Inventory Days2862,36814,7042,162337142345234230170
Days Payable2561,51732,2504,360510339521292340217
Cash Conversion Cycle70881-17,536-2,018-170-175-174-57-106-44
Working Capital Days-6-446-6,532-2,132-275-315-267-119-200-162
ROCE %-9%-15%-4%-8%-27%-27%-26%-36%-57%-42%-59%-29%

Krebs Biochemicals & Industries Ltd Financial Efficiency Indicators Chart

Krebs Biochemicals & Industries Ltd Share Holding Pattern

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Promoters72.74%72.74%72.74%72.74%72.74%72.74%72.72%72.74%72.74%72.74%72.74%72.74%
FIIs0.01%0.01%0.01%0.01%0.01%0.01%0.33%0.50%0.50%0.50%0.50%0.50%
Public27.25%27.25%27.25%27.25%27.25%27.26%26.95%26.76%26.77%26.76%26.77%26.75%
No. of Shareholders7,0968,5718,1669,5319,5339,6509,2949,3159,3939,0308,9908,909

Krebs Biochemicals & Industries Ltd Shareholding Pattern Chart

No. of Krebs Biochemicals & Industries Ltd Shareholders

This stock is not held by any mutual fund

Krebs Biochemicals & Industries Ltd ROCE Trend

Krebs Biochemicals & Industries Ltd EPS Trend

Krebs Biochemicals & Industries Ltd Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)-9.16-11.30-20.81-14.53-16.75
Diluted EPS (Rs.)-9.16-11.30-20.81-14.53-17.90
Cash EPS (Rs.)-6.01-8.41-17.73-11.84-13.44
Book Value[Excl.RevalReserv]/Share (Rs.)-55.29-46.13-34.83-21.78-13.89
Book Value[Incl.RevalReserv]/Share (Rs.)-55.29-46.13-34.83-21.78-13.89
Revenue From Operations / Share (Rs.)23.3924.1827.6927.3718.56
PBDIT / Share (Rs.)-3.84-7.03-15.23-8.64-10.15
PBIT / Share (Rs.)-6.97-10.07-18.15-11.25-12.75
PBT / Share (Rs.)-9.15-11.45-20.65-14.45-16.04
Net Profit / Share (Rs.)-9.15-11.45-20.65-14.45-16.04
PBDIT Margin (%)-16.40-29.07-55.00-31.57-54.66
PBIT Margin (%)-29.82-41.65-65.55-41.11-68.67
PBT Margin (%)-39.12-47.36-74.58-52.80-86.41
Net Profit Margin (%)-39.12-47.36-74.58-52.80-86.41
Return on Capital Employeed (%)-12.92-17.25-35.02-19.88-25.30
Return On Assets (%)-11.07-14.11-23.45-17.81-21.57
Long Term Debt / Equity (X)-1.54-0.43-0.03-2.35-2.62
Total Debt / Equity (X)-1.62-0.53-0.17-2.35-2.62
Asset Turnover Ratio (%)0.280.280.340.360.24
Current Ratio (X)0.280.320.450.440.43
Quick Ratio (X)0.120.080.120.090.08
Inventory Turnover Ratio (X)0.490.812.191.621.60
Interest Coverage Ratio (X)-1.76-5.10-6.09-2.70-3.08
Interest Coverage Ratio (Post Tax) (X)-3.21-7.30-7.26-3.52-3.87
Enterprise Value (Cr.)324.85304.75451.99274.16212.76
EV / Net Operating Revenue (X)6.445.857.575.116.37
EV / EBITDA (X)-39.27-20.10-13.76-16.17-11.65
MarketCap / Net Operating Revenue (X)2.612.335.183.254.41
Price / BV (X)-1.10-1.22-4.12-4.08-5.90
Price / Net Operating Revenue (X)2.612.335.183.254.41
EarningsYield-0.14-0.20-0.14-0.16-0.19

Krebs Biochemicals & Industries Ltd Profitability Ratios (%)

Krebs Biochemicals & Industries Ltd Liquidity Ratios

Krebs Biochemicals & Industries Ltd Liquidity Ratios (%)

Krebs Biochemicals & Industries Ltd Interest Coverage Ratios (%)

Krebs Biochemicals & Industries Ltd Valuation Ratios

Fair Value

Fair Value: 126.91

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 74.33% compared to the current price 72.8

Default values used*: Deafault value of 15 for Stock P/E is used, Deafault value of 15% for ROE is used

Intrinsic Value: 189.29

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 160.01% compared to the current price ₹72.8

Default values used*: Deafault value of 15 for Stock P/E is used, Deafault value of 15% for ROE is used

Last 5 Year EPS CAGR: 49.15%

*Investments are subject to market risks

Strength and Weakness of Krebs Biochemicals & Industries Ltd Stock

StrengthWeakness
  1. The stock has a low average Working Capital Days of -149.83, which is a positive sign.
  1. The stock has a low average ROCE of -28.25%, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 17.17, which may not be favorable.
  3. The company has higher borrowings (24.62) compared to reserves (-40.46), which may suggest financial risk.
  4. The company has not shown consistent growth in sales (31.92) and profit (-20.38).

FAQ

What is the latest fair value of Krebs Biochemicals & Industries Ltd?

The latest fair value of Krebs Biochemicals & Industries Ltd is ₹126.91.

What is the Market Cap of Krebs Biochemicals & Industries Ltd?

The Market Cap of Krebs Biochemicals & Industries Ltd is 157 Cr..

What is the current Stock Price of Krebs Biochemicals & Industries Ltd as on 21 June 2024?

The current stock price of Krebs Biochemicals & Industries Ltd as on 21 June 2024 is ₹72.8.

What is the High / Low of Krebs Biochemicals & Industries Ltd stocks in FY 2024?

In FY 2024, the High / Low of Krebs Biochemicals & Industries Ltd stocks is 94.0/60.0.

What is the Stock P/E of Krebs Biochemicals & Industries Ltd?

The Stock P/E of Krebs Biochemicals & Industries Ltd is .

What is the Book Value of Krebs Biochemicals & Industries Ltd?

The Book Value of Krebs Biochemicals & Industries Ltd is 55.3.

What is the Dividend Yield of Krebs Biochemicals & Industries Ltd?

The Dividend Yield of Krebs Biochemicals & Industries Ltd is 0.00 %.

What is the ROCE of Krebs Biochemicals & Industries Ltd?

The ROCE of Krebs Biochemicals & Industries Ltd is 10.4 %.

What is the ROE of Krebs Biochemicals & Industries Ltd?

The ROE of Krebs Biochemicals & Industries Ltd is %.

What is the Face Value of Krebs Biochemicals & Industries Ltd?

The Face Value of Krebs Biochemicals & Industries Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Krebs Biochemicals & Industries Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE